cp wire

CP Wire Articles

Omeros Receives Orphan Designation in Europe for Treatment in Hematopoietic Stem Cell Transplantation
  • OMS721 is also being studied in atypical hemolytic uremic syndrome, IgA nephropathy, and lupus nephritis
  • The drug also has orphan status for the treatment of primary IgA nephropathy... read more
Tue, 08/28/18 - 11:53 am
ReflectionBio Receives Orphan Drug Designation For Rare Eye Disease



Reflection Biotechnologies Limited ("ReflectionBio") announced on 8/28/18 that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to ReflectionBio's RBIO-101... read more

Tue, 08/28/18 - 09:20 am
Bio-Path Doses First Patient in Ph II Expansion Trial in Acute Myeloid Leukemia

  • The primary objective of the study is to determine whether the combination of prexigebersen and LDAC provides greater efficacy than would be expected with LDAC alone... read more

Mon, 08/27/18 - 09:49 am
Magnolia Neurosciences Receives $20 Million CPRIT Grant to Develop Therapies to Treat Chemotherapy-Induced Neurological Conditions


Magnolia Neurosciences Corporation (Magnolia) announced on 8/27/18 that Korysso Therapeutics, Inc. (DBA: Magnolia Tejas Corporation), the company’s wholly owned, Houston-based subsidiary, has... read more

Mon, 08/27/18 - 09:22 am
LifeMax Acquires Rights to Orphan Drug for Netherton Syndrome from Novartis

LifeMax Laboratories, Inc. (“LifeMax”) announced on 8/27/18 an exclusive worldwide license from Novartis Pharma AG for the right to develop, manufacture and commercialize BPR277, a clinical stage... read more

Mon, 08/27/18 - 09:12 am

Pages